ScholarIQanswers from OpenAlex

Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy

PaperCitations, authors & open-access status

Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy have?

ScholarIQcitation count

Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy has 208 citations in the OpenAlex counts ScholarIQ stores.

When was Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy published?

ScholarIQyear

Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy has 2019 year in the ScholarIQ index.

What is the open-access status of Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy?

ScholarIQoa status

Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy has bronze oa status in the ScholarIQ index.

What is the DOI of Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy?

ScholarIQdoi

The DOI for Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy is on the source record.

What is the PMID of Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy?

ScholarIQpmid

The PMID for Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy is on the source record.

What is the OpenAlex record for Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy?

ScholarIQopenalex

The OpenAlex for Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial